Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions
Rona Therapeutics presented positive results from the Phase 1 clinical trial of RN0191 at the American Heart Association's (AHA) Annual Scientific Sessions in Chicago, IL, November 16th, 2024.
November 20, 2024
by PR NEWSWIRE
AzarGen Presents AZprom™ - Superior Synthetic Promotors to Enhance Molecular Farming Applications
AzarGen presents AZprom™ - Superior Synthetic Promotors and it shows a dramatic increase in the expression of fluorescent proteins, outperforming the ‘double-enhancer’ CaMV 35S promoter more than 5-fold in transgenic tobacco plants.
July 10, 2024
by Biotech Newswire
Vetter Earns Prestigious Honors Across All Core Categories in the 13th Annual CDMO Leadership Awards
Vetter once again earned the 2024 CDMO Leadership Awards in all six core categories – quality, expertise, reliability, capabilities, compatibility and service for big pharma, small pharma and overall respondents.
March 27, 2024
by PharmaSources
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics
On January 4, 2024, Beijing time, Allorion Therapeutics announced that it has entered into a transfer agreement with Avenzo Therapeutics, Inc. (Avenzo) of the United States
January 5, 2024
by B3CNewswire
Vetter’s European Clinical Site Receives Permanent Manufacturer’s Authorization
Vetter, a leading global Contract Development and Manufacturing Organization (CDMO), has received the permanent Manufacturer’s Authorization for its clinical development site in Rankweil, Austria.
November 16, 2023
by B3C newswire
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
May 10, 2023
by PharmaSources
International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.
HongKe(虹科) Technology Co., Ltd., established in 2007 (previously HongKe(宏科) founded in 1995), is headquartered in Guangzhou, the economic and cultural center of southern China.
May 27, 2022
by PharmaSources.com
Biotech and pharma services outsourcing market to be worth over $91bn by 2028
A new report suggests the global biotechnology and pharmaceutical services outsourcing market will grow because of the pandemic and rising drug development costs and R&D investments.
April 14, 2021
by europeanpharmaceuticalreview
Thailand BOI Okays Biotech Projects Worth 2.4 Bln Baht in Total Investment
The Thailand Board of Investment (BOI) said it has recently approved new projects in the field of advanced biotechnology, worth a combined 2.4 billion baht (around USD78 million) in investment, reflecting the increased interest of local and foreign ...
April 8, 2021
by prnasia
Discovering Biotechnology: Top 9 Chinese Pharmaceutical Companies in 2020
China 's pharmaceutical industry garnered a total revenue of about 2.6 trillion yuan in 2019 amounting to an eight percent year-on-year growth.
November 4, 2020
by Deborah Seah
INSERM leads in patent applications, reports European Patent Office
According to the European Patent Office (EPO), in 2019 the number of patents filed in the pharmaceutical and biotechnology sectors rose for a third consecutive year.
March 13, 2020
by europeanpharmaceuticalreview
Malaysia to host Biotechnology 2019 summit
Malaysia is emphasizing on recent areas of more optimized research techniques in Biotech and Genetic technologies
August 21, 2019
by biospectrumasia